GW117 ODT （Orally Disintegrating Tablets） Safety and Pharmacokinetics Study in Healthy Subjects
Clinical trial NCT06964711 · COMPLETED
Trial details
- NCT number
- NCT06964711
- Sponsor
- Beijing Greatway Pharmaceutical Technology Co.,Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-12
- Primary completion
- 2023-03-24
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.